Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Hosted on MSN16d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
Trump Order Didn’t Reverse All of Biden’s Measures to Lower Drug Costs
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
Beta Bionics targets $114M IPO raise to fund insulin pump development
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
KHOU 1110d
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
Serial biotech entrepreneur targets obesity with drug fished out of bankruptcy court
A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...
Newsweek15d
Gavin Newsom Underestimated Deadline for Bold Insulin Plan by Years
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...
San Diego Reader8d
Newsom’s $100 million San Diego insulin give-away stalls
Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...
Knowridge13d
Research shows serious risk linked to diabetes drugs
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to treat diabetes, have recently been ...
Newsweek15d
Red 3 Ban: Other Ingredients That Could Now Face FDA Scrutiny
The Food and Drug Administration has banned Red Dye No ... high triglycerides, insulin resistance, high blood sugar and an increased risk of Type 2 diabetes. The sweetener is often used in ...